英国头颈部黏膜黑色素瘤国家指南
英国头颈部黏膜黑色素瘤指南制定组采用循证系统方法,针对诊断与分期、手术及辅助放疗与靶向和免疫等新型系统治疗的选择路径、治疗后监测等关键不确定领域提出推荐。指南经国际同行评议并获NICE认证,本文汇总关键推荐,全文见Melanoma Focus网站。
要点
- 指南覆盖诊断分期、手术、辅助放疗、靶向与免疫治疗及治疗后监测。
- 推荐基于循证系统方法形成,并经国际同行评议与NICE认证。
- 关键推荐摘要见本文,完整文件见Melanoma Focus网站。
核心结论
- 英国国家指南针对头颈部黏膜黑色素瘤诊断分期、治疗路径与治疗后监测等不确定领域给出循证推荐。
研究设计与样本
- 由英国头颈部黏膜黑色素瘤指南制定组采用循证系统方法制定,并经国际同行评议与NICE认证。
关键数值与推荐
- 推荐覆盖准确诊断与分期、包括手术与辅助放疗及靶向和免疫等新型系统治疗的治疗路径、治疗后患者监测。
临床怎么用
- 临床可依据该指南在诊断分期、治疗选择与治疗后监测等关键环节进行决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The United Kingdom head and neck mucosal melanoma guideline development group used an evidence-based systematic approach to make recommendations in key areas of uncertainty in the field, including accurate diagnosis and staging; the appropriate treatment pathway including surgery, adjuvant radiation and new systemic treatments, such as targeted agents and immunotherapy; and the surveillance of patients after treatment. The guidelines were sent for international peer review and have been accredited by the National Institute for Health and Care Excellence. A summary of key recommendations is presented. The full documents are available on the Melanoma Focus website (https://melanomafocus.com/activities/mucosal-guidelines/mucosal-melanoma-resources/).
引用
- Nenclares P, Ap Dafydd D, Bagwan I, et al. Head and neck mucosal melanoma: The United Kingdom national guidelines. Eur J Cancer. 2020. PMID: 32829104. doi:10.1016/j.ejca.2020.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。